YOLFTbeta
00

Samil Pharm

000520 · KO · Healthcare / Drug Manufacturers - Specialty & Generic

7,170.00KRW-240.00 (-3.24%)

Price History

Full chart

Market Stats

Previous Close7,410.00
Open7,410.00
Day Range7,130.00 – 7,640.00
52-Week Range5,500.00 – 12,860.00
Volume52.09K
Market Cap175.45B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
Beta0.34
50-Day Avg6,830.80
200-Day Avg8,495.95

About

Samil Pharmaceutical Co.,Ltd engages in the manufacture and sale of pharmaceuticals in South Korea. It offers general medicines, including Tiersil Once, EYE2O mini eye drops, and Optagent ophthalmic drops; medical devices; secret spotpatch quasi-drugs, and roll away products. The company also provides specialty medicines, such as Hycell solutions; Curelen, Ocufridine, Ocumetholone, Ocucyclo, Ocuhomapine, Ocucarpine, Allerfen, Optanac, Forus, Eymox, Cifex, and Ocuracin ophthalmic drops; and Herpecid, Forus, and Ocurasin ophthalmic ointments. Samil Pharmaceutical Co.,Ltd was founded in 1947 and is headquartered in Seoul, South Korea.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOSeung Bum Huh
  • Employees583
  • Headquarters155 Hyoryeong-Ro, Seoul, South Korea, Korea
  • Websitehttps://www.samil-pharm.com

Leadership

  • Seung Bum HuhCEO & Chairman · b. 1981
  • Yu Seok ShinPresident & Director · b. 1973
  • Joon Beom HuhExecutive Director · b. 1985

Financials

Income Statement

Currency: KRW2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue94.48B91.44B89.23B85.46B88.14B96.76B92.04B94.60B121.11B123.00B134.25B179.68B196.35B219.70B210.25B
Growth (%)--3.21%-2.42%-4.22%+3.13%+9.78%-4.88%+2.78%+28.02%+1.56%+9.14%+33.84%+9.28%+11.89%-4.30%
Cost of Revenue53.77B51.03B50.45B48.78B51.06B55.31B51.13B59.81B74.38B73.97B85.26B112.19B122.28B138.79B133.13B
Gross Profit--35.84B33.71B37.07B41.45B40.91B34.79B46.72B49.03B48.99B67.49B74.07B80.91B77.12B
Gross Margin--40.16%39.44%42.06%42.84%44.44%36.78%38.58%39.86%36.49%37.56%37.72%36.83%36.68%
Operating Expense--37.81B42.87B35.47B37.60B39.60B40.52B41.90B42.49B48.59B63.47B67.60B80.80B99.33B
Operating Income---1.98B-9.17B1.60B3.85B1.31B-5.73B4.82B6.54B399.74M4.02B6.47B113.04M-22.21B
Operating Margin---2.22%-10.73%1.82%3.98%1.42%-6.06%3.98%5.32%0.30%2.24%3.30%0.05%-10.56%
EBITDA------4.70B-2.05B9.37B10.90B6.15B10.31B10.34B8.71B-19.14B
EBITDA Margin------5.11%-2.17%7.74%8.86%4.58%5.74%5.26%3.96%-9.10%
Net Income--7.93B-11.19B588.37M886.60M-1.27B-8.56B786.26M1.34B-5.35B-28.29M1.66B-5.63B-34.66B
Net Income Margin--8.89%-13.09%0.67%0.92%-1.38%-9.05%0.65%1.09%-3.98%-0.02%0.85%-2.56%-16.49%
R&D3.82B-2.05B2.79B1.12B1.25B1.96B2.18B3.06B3.01B2.97B2.91B5.60B6.51B8.46B
R&D as % of Total Revenue4.05%-2.29%3.26%1.27%1.30%2.13%2.31%2.53%2.44%2.21%1.62%2.85%2.96%4.03%
Interest Expense00000002.39B3.90B5.51B6.20B4.26B3.54B5.06B8.77B
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%2.53%3.22%4.48%4.62%2.37%1.81%2.30%4.17%

Balance Sheet

Currency: KRW2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets121.20B111.00B115.71B108.29B99.31B101.00B135.48B147.95B183.87B191.66B226.40B356.70B370.68B395.07B371.60B
Total Liabilities54.60B48.12B45.68B52.88B44.90B48.12B84.31B91.87B121.60B128.11B160.66B230.88B242.85B218.95B238.34B
Total Equity66.60B62.87B70.03B55.42B54.41B52.87B51.17B56.08B62.27B63.55B65.75B125.82B127.83B176.12B133.26B
Cash4.16B13.39B23.36B1.28B3.41B6.17B991.23M2.99B16.72B16.00B3.99B1.90B906.14M5.14B6.41B
Net Debt------60.21B63.72B76.32B77.78B120.21B155.52B173.36B142.60B155.66B

Cash Flow

Currency: KRW2004-12-312005-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow---5.02B-3.99B-11.92B2.92B5.63B3.79B-2.62B10.59B7.77B1.42B4.15B11.75B2.59B568.16M
Investing Cash Flow--10.73B12.52B20.21B-17.47B9.45B-2.86B-37.50B-14.77B-26.05B-4.59B-45.31B-35.94B---
Financing Cash Flow-----6.14B7.32B-10.24B-132.22M28.53B19.45B29.06B-3.32B31.87B29.71B---
Capital Expenditure004.84B1.91B1.84B5.29B2.36B4.45B36.33B3.70B13.89B17.02B32.83B48.48B24.39B5.61B7.52B
Free Cash Flow---------39.55B-6.54B-3.89B-9.44B-31.67B-44.50B-12.65B-3.02B-6.95B
Dividends Paid----782.03M782.03M1.02B1.02B765.53M765.53M610.35M918.89M938.64M1.00B---
FCF to OCF---------1043.08%249.37%-36.74%-121.37%-2235.50%-1071.33%-107.66%-116.69%-1224.08%
Dividend Paid to FCF---------1.94%-11.71%-15.69%-9.74%-2.96%-2.25%---

Earnings

Report DateMay 16, 2005Jul 28, 2005May 15, 2006Jun 3, 2009Sep 2, 2009Dec 2, 2009Mar 15, 2010May 15, 2010Aug 15, 2010Nov 15, 2010May 15, 2011Aug 31, 2011Nov 30, 2011May 30, 2012Aug 29, 2012Nov 28, 2012Feb 27, 2013May 24, 2013Aug 28, 2013Nov 28, 2013Mar 28, 2014May 30, 2014Aug 28, 2014Nov 27, 2014Mar 13, 2015Jun 3, 2015Sep 2, 2015Dec 2, 2015Mar 2, 2016May 13, 2016Aug 12, 2016Nov 14, 2016Mar 31, 2017May 12, 2017Aug 11, 2017Nov 14, 2017Mar 30, 2018May 30, 2018Aug 10, 2018Nov 28, 2018Feb 27, 2019May 29, 2019Aug 9, 2019Nov 14, 2019Feb 26, 2020May 8, 2020Aug 14, 2020Nov 13, 2020Mar 11, 2021May 18, 2021Aug 13, 2021Nov 22, 2021Mar 16, 2022May 9, 2022Aug 12, 2022Nov 14, 2022Jan 19, 2023May 14, 2023Aug 11, 2023Nov 14, 2023Mar 14, 2024May 13, 2024Aug 14, 2024Nov 14, 2024Feb 3, 2025May 15, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate278.35146.56244.17--------------------------------------------------------------------
EPS Actual9.06195.21280.00-52.56-132.14910.39-151.5423.41113.77-35.15211.94-120.43-80.3348.29-29.70-5.97-337.5025.80-19.97-48.06710.34-36.48-323.82-260.23-336.2149.7415.6713.84-28.6246.68-19.8428.1421.3351.93-24.08-172.6235.76-79.80-185.94-209.71-222.1387.4574.86-33.33-70.16134.8323.21-17.70-39.5944.20-83.77-120.21-226.1726.83-19.68-152.00142.5954.6135.40-46.1261.82-118.0721.19-38.76-167.71-427.74-306.07-373.30-525.68-509.07-359.85
Surprise-96.75%33.19%14.67%--------------------------------------------------------------------
Timing--Pre-market---After-hoursPre-marketPre-marketPre-marketPre-market------After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours----After-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hours---------After-hoursPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hours-Pre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-market-Pre-market-After-hoursPre-market-----

Key Statistics & Ratios

Market Cap175.45B
Enterprise Value343.05B
Trailing P/E0.00
Forward P/E0.00
PEG Ratio0.00
Price / Sales0.85
Price / Book1.38
Revenue (TTM)207.33B
Gross Profit (TTM)73.95B
EBITDA-20.70B
Profit Margin-18.14%
Operating Margin-12.53%
Return on Equity-27.37%
Return on Assets-5.03%
Shares Outstanding21.37M
Shares Float16.31M
Beta0.34
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20221×
80.00Dec 28, 2022
20211×
72.73Dec 29, 2021
20201×
68.18Dec 29, 2020
20191×
68.18Dec 27, 2019
20181×
45.45Dec 27, 2018
20171×
65.89Dec 27, 2017
20161×
65.89Dec 28, 2016
20151×
87.85Dec 29, 2015
20141×
87.85Dec 29, 2014
20131×
65.89Dec 27, 2013
20121×
56.66Dec 27, 2012
20111×
65.89Dec 28, 2011
20101×
87.85Dec 29, 2010
20091×
87.85Dec 29, 2009
20081×
96.63Dec 29, 2008
20071×
144.95Dec 27, 2007
20061×
144.95Dec 27, 2006
20051×
144.95Dec 28, 2005
20041×
120.79Dec 29, 2004
20031×
120.79Dec 29, 2003
20021×
96.63Dec 27, 2002
20012×
72.48Dec 27, 200148.32Jan 2, 2001
20001×
9.17Jan 4, 2000

Stock Splits

  • Mar 24, 20231.1:1
  • Apr 12, 20212:1
  • Apr 19, 20065:1
  • Jan 2, 20011.0536:1
  • Jan 4, 20001.0708:1